Research Article
Alexander K. C. Leung, MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP1,2*, and Benjamin Barankin, MD, FRCPC3
1Clinical Professor of Pediatrics, University of Calgary
2Pediatric Consultant, Alberta Children's Hospital
3Dermatologist, Medical Director and Founder, Toronto Dermatology Centre
Corresponding author
Dr. Alexander K.C. Leung, Clinical Professor of Pediatrics, University of Calgary, #200, 233 â?? 16th Avenue NW, Calgary, Alberta, Canada T2M 0H5, Tel: (403) 230-3300; Fax: (403) 230-3322; E-mail: aleung@ucalgary.ca
Received Date: 24th May 2015
Accepted Date: 23rd June 2015
Published Date: 26th June 2015
Citation
Leung AK, Barankin B (2015) Dermatosis Papulosa Nigra. Enliven: Clin Dermatol 1(5): 008.
Copyright
@ 2015 Dr. Alexander K.C. Leung. This is an Open Access article published and distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Dermatosis papulosa nigra is a common, benign skin condition characterized by multiple, asymptomatic, superficial, black or dark-brown, round, domeshaped or flat, macules or more often papules. The size of individual lesion usually ranges from 1 to 5 mm. Sites of predilection include the face, neck, and upper trunk. Dermatosis papulosa nigra occurs predominantly in darker-skinned individual. The incidence increases with age and is rare before puberty. The male to female ratio is approximately 1:2. There is a genetic predisposition. Ultraviolet irradiation may have a role to play. Activating point mutations of the FGFR3 and the PIK3CA genes are involved in the pathogenesis. Treatment is usually not necessary apart from reassurance about the benign nature of the condition. For those patients in whom treatment is desired mainly for esthetic reasons, treatment options most commonly include: curettage, ablative laser, excision, and electrofulguration. Liquid nitrogen cryotherapy can also be tried in some cases with great care due to higher risk of side effects.
Keywords
Hyperpigmentation; Papules; Dark-skin; Mutations; FGFR3; PIK3CA; Benign; Reassurance
Introduction
Dermatosis papulosa nigra is a common, benign skin condition characterized by multiple, asymptomatic, pigmented, round, dome-shaped or flat, papules or macules localized predominately on the face, neck, and upper trunk [1,2]. The condition was first described by Aldo Castellani in 1925, based on his observations made while visiting Central America and Jamaica [3].
Epidemiology
Dermatosis papulosa nigra occurs predominantly in dark-skinned individual (Fitzpatrick skin phototypes IV to VI) [2]. The incidence in adult blacks is between 10 and 30% [2]. Asian patients are also prone to these lesions. The condition is rare in Caucasians [4]. The incidence increases with age and is rare before puberty [4,5]. The peak incidence is in the sixth decade [4,5]. The male to female ratio is approximately 1:2 [4,6].
Etiopathology
The exact etiology is not known. It is believed that the condition is caused by a defect in the nevoid development of the pilosebaceous follicle [4]. There is a genetic predisposition as there is a positive family history in approximately 50% of affected individuals [1,4]. As the condition occurs mainly in the sun-exposed areas, ultraviolet irradiation may have a role to play. It has been shown that activating point mutations of the FGFR3 (fibroblast growth factor 3) and the PIK3CA (encoding for the catalytic p110 subunit of class 1 phosphatidylinositol 3-kinase) genes are involved in the pathogenesis of dermatosis papulosa nigra [7]. Some authors consider dermatosis papulosa nigra to be a variant of seborrheic keratosis in people with dark skin [7].
Histopathology
Histological examination of the lesion shows hyperkeratosis, papillomatosis, and acanthosis, invaginations of the epidermis with elongation of the rete ridges (horn cysts), and marked hyperpigmentation of the basal layer [8].
Clinical Manifestations
Clinically, dermatosis papulosa nigra presents as multiple, asymptomatic, superficial, black or dark-brown, round, dome-shaped or flat, macules or more often papules (Figure 1) [2]. In the early stage, the lesions are often smooth-surfaced. Later, they become roughened and at times verrucous. Some of the lesions may be filiform or pedunculated. The size of individual lesion usually ranges from 1 to 5 mm [9]. Sites of predilection include the face (predominantly the malar regions), neck, and upper trunk [2]. They do not tend to group or occur in a linear fashion. The lesions increase in size and number over time.
Figure 1. Dermatosis papulosa nigra presenting as multiple, smooth, dark-brown, round, dome-shaped papules in the malar area of a black woman.
The diagnosis is mainly clinical. No investigation is necessary. A biopsy should be considered if the diagnosis is in doubt. Differential diagnosis includes adenoma sebaceum, melanocytic nevi, verrucae, acrochordons, follicular hamartomas, and seborrheic keratosis [5]. Dermatosis papulosa nigra can be cosmetically unsightly and may affect interpersonal relationships. Other complications include mechanical irritation and, less commonly, inflammation, bleeding, pruritus, and pain [9]. An abrupt increase in dermatosis papulosa nigra may be a sign of internal malignancy [10]. The condition is benign and without any malignant potential. However, the lesions tend to persists and do not self-resolve. Some lesions will slowly enlarge and newer lesions develop over time. Treatment is usually not necessary apart from reassurance about the benign nature of the condition [8]. For those patients in whom treatment is desired mainly for esthetic reasons, treatment options most commonly include curettage, ablative laser, excision, and electrofulguration [8,9]. Liquid nitrogen can also be used in some cases with great care due to higher risk of side effects [8,9]. This is because melanocytes are very sensitive to very cold temperature.
Diagnosis
Differential Diagnosis
Complications
Prognosis
Treatment
References